Antiviral activity of microalgae extracts against Mayaro virus

2022 ◽  
Vol 61 ◽  
pp. 102577
Author(s):  
Michele Caldeira Magdalena Ribeiro ◽  
Tiago Souza Salles ◽  
Mônica Ferreira Moreira ◽  
Elisabete Barbarino ◽  
Anita Ferreira do Valle ◽  
...  
2021 ◽  
Author(s):  
Tiago Souza Salles ◽  
Marcelo Damião Ferreira Meneses ◽  
Lucio Ayres Caldas ◽  
Thayane Encarnação Sá-Guimaraes ◽  
Danielle M. de Oliveira ◽  
...  

Abstract Background: The arthropod-borne Mayaro virus (MAYV) causes ‘Mayaro fever’, a disease of medical significance, primarily affecting individuals in permanent contact with forested areas in tropical South America. Recently, MAYV has attracted attention due to its likely urbanization. Currently, there are no licensed drugs against most mosquito-transmitted viruses. Punica granatum (pomegranate) fruits cultivated in Brazil were submitted to a phytochemical investigation for the identification and isolation of antiviral compounds. In the present study we studied the antiviral activity of pomegranate extracts in Vero cells infected with Mayaro virus. Methods: The Ethanol extract and Punicalagin of Pomegranate were extracted solely of the shell and purified by chromatographic fractionation and chemically identified using spectroscopic techniques. Cytotoxicity of purified compounds was measured by the dye-uptake assay while their antiviral activity was evaluated by a virus yield inhibition assay.Results: Pomegranate ethanol extract (CC50 = 588.9, IC50 = 12.3) and a fraction containing punicalagin as major compound (CC50 = 441.5, IC50 = 28.2) were shown to have antiviral activity (SI 49 and 16, respectively) against Mayaro virus, an alphavirus. Immunofluorescence analysis showed the virucidal effect of Pomegranate extract and Transmission Electron Microscopy (TEM) revealed damage in viral particles treated with this extract. Conclusions: The P. granatum extract is a promising source of antiviral compounds against the alphavirus MAYV and are excellent candidates for future studies with other enveloped RNA viruses.


2018 ◽  
Vol 163 (6) ◽  
pp. 1567-1576 ◽  
Author(s):  
P. G. Ferreira ◽  
A. C. Ferraz ◽  
J. E. Figueiredo ◽  
C. F. Lima ◽  
V. G. Rodrigues ◽  
...  

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Helder V. Ribeiro-Filho ◽  
Lais D. Coimbra ◽  
Alexandre Cassago ◽  
Rebeca P. F. Rocha ◽  
João Victor da Silva Guerra ◽  
...  

AbstractMayaro virus (MAYV) is an emerging arbovirus of the Americas that may cause a debilitating arthritogenic disease. The biology of MAYV is not fully understood and largely inferred from related arthritogenic alphaviruses. Here, we present the structure of MAYV at 4.4 Å resolution, obtained from a preparation of mature, infective virions. MAYV presents typical alphavirus features and organization. Interactions between viral proteins that lead to particle formation are described together with a hydrophobic pocket formed between E1 and E2 spike proteins and conformational epitopes specific of MAYV. We also describe MAYV glycosylation residues in E1 and E2 that may affect MXRA8 host receptor binding, and a molecular “handshake” between MAYV spikes formed by N262 glycosylation in adjacent E2 proteins. The structure of MAYV is suggestive of structural and functional complexity among alphaviruses, which may be targeted for specificity or antiviral activity.


Viruses ◽  
2021 ◽  
Vol 13 (11) ◽  
pp. 2123
Author(s):  
Luciana S. Fernandes ◽  
Milene L. da da Silva ◽  
Roberto S. Dias ◽  
Marcel S. da S. da S. Lucindo ◽  
Ítalo E. P. da da Silva ◽  
...  

Mayaro virus (MAYV) is a neglected arthropod-borne virus found in the Americas. MAYV infection results in Mayaro fever, a non-lethal debilitating disease characterized by a strong inflammatory response affecting the joints and muscles. MAYV was once considered endemic to forested areas in Brazil but has managed to adapt and spread to urban regions using new vectors, such as Aedes aegypti, and has the potential to cause serious epidemics in the future. Currently, there are no vaccines or specific treatments against MAYV. In this study, the antiviral activity of a series of synthetic cyclic ketones were evaluated for the first time against MAYV. Twenty-four compounds were screened in a cell viability assay, and eight were selected for further evaluation. Effective concentration (EC50) and selectivity index (SI) were calculated and compound 9-(5-(4-chlorophenyl]furan-2-yl)-3,6-dimethyl-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2))-dione (9) (EC50 = 21.5 µmol·L–1, SI = 15.8) was selected for mechanism of action assays. The substance was able to reduce viral activity by approximately 70% in both pre-treatment and post-treatment assays.


2018 ◽  
Vol 158 ◽  
pp. 8-12 ◽  
Author(s):  
Fernanda Caetano Camini ◽  
Tales Fernando da Silva ◽  
Camila Carla da Silva Caetano ◽  
Letícia Trindade Almeida ◽  
Ariane Coelho Ferraz ◽  
...  

2020 ◽  
Author(s):  
Helder Ribeiro Filho ◽  
Lais D. Coimbra ◽  
Alexandre Cassago ◽  
Rebeca P. F. Rocha ◽  
Antonio Cláudio Padilha ◽  
...  

ABSTRACTMayaro virus (MAYV) is an emerging arbovirus of the Americas that may cause a debilitating arthritogenic disease. The biology of MAYV is not fully understood and largely inferred from related arthritogenic alphaviruses. Here we present the structure of MAYV at 4.4 Å resolution, obtained from a preparation of mature, infective virions. MAYV presents typical alphavirus features and organization. Interactions between viral proteins that lead to particle formation are described together with a hydrophobic pocket formed between E1 and E2 spike proteins and conformational epitopes specific of MAYV. We also describe MAYV glycosylation residues in E1 and E2 that may affect MXRA8 host receptor binding, and a molecular “handshake” between MAYV spikes formed by N262 glycosylation in adjacent E2 proteins. The structure of MAYV is suggestive of structural and functional complexity among alphaviruses, which may be targeted for specificity or antiviral activity.


2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Tiago Souza Salles ◽  
Marcelo Damião Ferreira Meneses ◽  
Lucio Ayres Caldas ◽  
Thayane Encarnação Sá-Guimarães ◽  
Danielle M. de Oliveira ◽  
...  

Abstract Background The arthropod-borne Mayaro virus (MAYV) causes “Mayaro fever,” a disease of medical significance, primarily affecting individuals in permanent contact with forested areas in tropical South America. Recently, MAYV has attracted attention due to its likely urbanization. There are currently no licensed drugs against most mosquito-transmitted viruses. Punica granatum (pomegranate) fruits cultivated in Brazil have been subjected to phytochemical investigation for the identification and isolation of antiviral compounds. In the present study, we explored the antiviral activity of pomegranate extracts in Vero cells infected with Mayaro virus. Methods The ethanol extract and punicalagin of pomegranate were extracted solely from the shell and purified by chromatographic fractionation, and were chemically identified using spectroscopic techniques. The cytotoxicity of the purified compounds was measured by the dye uptake assay, while their antiviral activity was evaluated by a virus yield inhibition assay. Results Pomegranate ethanol extract (CC50 = 588.9, IC50 = 12.3) and a fraction containing punicalagin as major compound (CC50 = 441.5, IC50 = 28.2) were shown to have antiviral activity (SI 49 and 16, respectively) against Mayaro virus, an alphavirus. Immunofluorescence analysis showed the virucidal effect of pomegranate extract, and transmission electron microscopy (TEM) revealed damage in viral particles treated with this extract. Conclusions The P. granatum extract is a promising source of antiviral compounds against the alphavirus MAYV and represents an excellent candidate for future studies with other enveloped RNA viruses. Graphical abstract


Planta Medica ◽  
2009 ◽  
Vol 75 (09) ◽  
Author(s):  
C Thaele ◽  
A Janecki ◽  
AF Kiderlen ◽  
H Kolodziej

Sign in / Sign up

Export Citation Format

Share Document